Literature DB >> 25578435

Anticonvulsant and neurological profile of benzothiazoles: a mini-review.

Jagbir Gagoria, Prabhakar Kumar Verma, Anurag Khatkar1.   

Abstract

From last few years research work on heterocyclic compound and their derivatives has been increasing. Benzothiazole molecule has a heterocyclic structure, basic in nature with wide variety of active sites. As a small molecule, it contains electronegative atoms due to which it is feasible for other moieties to form conjugates. Referring to the bioorganic and medicinal chemistry, the moiety has potential to give active pharmacophores to develop new therapeutically important compounds. Benzothiazole derivatives were found to exhibit efficacy against some very serious diseases like cancer, neurodegeneration, neuropathic pain, infectious diseases, epilepsy etc. In the present review, antiepileptic profile of benzothiazole derivatives is emphasized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25578435     DOI: 10.2174/1871524915666150112094206

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  3 in total

1.  Synthesis and Antinociceptive Effect of Some Thiazole-Piperazine Derivatives: Involvement of Opioidergic System in the Activity.

Authors:  Nazlı Turan Yücel; Derya Osmaniye; Ümmühan Kandemir; Asaf Evrim Evren; Özgür Devrim Can; Ümide Demir Özkay
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

2.  Synthesis, Computational Studies and Anticonvulsant Activity of Novel Benzothiazole Coupled Sulfonamide Derivatives.

Authors:  Sukhbir L Khokra; Kanika Arora; Shah A Khan; Pawan Kaushik; Reetu Saini; Asif Husain
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

3.  Anticonvulsant and Toxicological Evaluation of Parafluorinated/Chlorinated Derivatives of 3-Hydroxy-3-ethyl-3-phenylpropionamide.

Authors:  Osvaldo Garrido-Acosta; Sergio E Meza-Toledo; Liliana Anguiano-Robledo; Marvin A Soriano-Ursúa; José Correa-Basurto; Asghar Davood; Germán Chamorro-Cevallos
Journal:  Biomed Res Int       Date:  2016-02-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.